Estimated Comparative Effectiveness
After weighting, mean DAS28-CRP decreased from 5.3 (95% CI, 5.2-5.4) at baseline to 2.6 (95% CI, 2.5-2.7) at 3 months and 2.3 (95% CI, 2.2-2.4) at 9 months in the ADA group (eResults 5 in The ATE for TOF compared with ADA was −0.2 (95% CI, −0.4 to −0.03; 